Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03502746 · OUTCOME

Overall Survival

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma · Source last updated 2024-05-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Months
Interval / dispersion
95% Confidence Interval
Time frame
Time of treatment start until death or date of last contact, up to a maximum of 32 months.

What was measured

Overall survival (OS) is defined as time of treatment start until death or date of last contact.

Groups in this outcome

Nivolumab + Ramucirumab

Nivolumab 240mg IV + Ramucirumab 8mg/kg IV Nivolumab: Nivolumab 240mg, IV over 30 minutes. Ramucirumab: 8mg/kg, IV over 60 minutes.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Nivolumab + Ramucirumab34

Reported measurements

Source class 1
Values in Months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Nivolumab + Ramucirumab12.5Not reported6.323.5Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        6.3
        upper Limit
        23.5
        value
        12.5
denoms
  1. counts
    1. group Id
      OG000
      value
      34
    units
    Participants
description
Overall survival (OS) is defined as time of treatment start until death or date of last contact.
dispersion Type
95% Confidence Interval
groups
  1. description
    Nivolumab 240mg IV + Ramucirumab 8mg/kg IV Nivolumab: Nivolumab 240mg, IV over 30 minutes. Ramucirumab: 8mg/kg, IV over 60 minutes.
    id
    OG000
    title
    Nivolumab + Ramucirumab
param Type
MEDIAN
reporting Status
POSTED
time Frame
Time of treatment start until death or date of last contact, up to a maximum of 32 months.
title
Overall Survival
type
SECONDARY
unit Of Measure
Months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice